Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable iron versus oral ferrous sulfate for postpartum iron deficiency anemia
IRCT20231023059817N4Phase 3Completed
- Sponsor
- Zist Aru Danesh
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postpartum anemia and iron deficiency anemia (IDA) comparing Injectable iron with Oral ferrous sulfate (2 arms). Primary endpoints: Hemoglobin response, Quality of life change and 2 more. Started Sep 2024; status: completed.
02
Drugs
Ironferrous sulfate
03
Conditions
postpartum anemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on IRCT20231023059817N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231023059817N4.